IG Group Holdings PLC

Board/Management Information • Sep 15, 2025

National Storage Mechanism | Additional information

RNS Number : 3060Z

IG Group Holdings plc

15 September 2025

15 September 2025

LEI No: 2138003A5Q1M7ANOUD76

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

IG GROUP HOLDINGS PLC

Group Chair Succession

IG Group Holdings plc ("IG", "the Group") today provides an update on IG Group Chairman succession.

Mike McTighe has informed the Board of his intention to step down as Chairman by the end of 2025. Having served in this role since his appointment in February 2020, Mike commented: "It has been a great honour and privilege to lead the Board over the past five years. I am grateful for the trust and support I have received from colleagues. With solid foundations laid for stronger growth, I am confident that under Breon Corcoran's leadership, IG will go from strength to strength."

Senior Independent Non-Executive Director, Jonathan Moulds, commented: "On behalf of the Board and all our colleagues at IG, I want to thank Mike for his guidance and leadership over the past five years."

Mike McTighe will stand for re-election at the Group's Annual General Meeting on 17 September 2025. The process for appointing a successor is underway.

Enquiries

IG Group Investor Relations	Media
Martin Price 020 7573 0020	Sodali & Co 020 7100 6451
[email protected]	[email protected]

About IG

IG Group (LSEG:IGG) provides online trading platforms and educational resources to empower ambitious clients around the globe. Headquartered in the UK, IG Group is a FTSE 250 company that offers clients access to c.19,000 financial markets worldwide.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUSAARVAUKAUR